Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.966.836.735.383.82

What is the latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JENBURKT PHARMACEUTICALS is 5.96 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar20245.96
Mar20236.83
Mar20226.73
Mar20215.38
Mar20203.82

How is EV/Core EBITDA of JENBURKT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 5.96
-12.74
Mar2023 6.83
1.49
Mar2022 6.73
25.09
Mar2021 5.38
40.84
Mar2020 3.82 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹551.3 Cr 23.7% 20.8% 107.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,604.0 Cr 0.1% -4% 52.9% Stock Analytics
DIVIS LABORATORIES ₹157,639.0 Cr 0.7% -0% 70.9% Stock Analytics
CIPLA ₹128,549.0 Cr 0.5% -1.7% 29.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,956.0 Cr 1.1% -2.6% 19.2% Stock Analytics
ZYDUS LIFESCIENCES ₹97,468.9 Cr -3.6% -8.4% 62.9% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

23.7%

20.8%

107.5%

SENSEX

-0.3%

-2.4%

22.4%


You may also like the below Video Courses